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Abstract
Rationale: The application of prone positioning for acute
respiratory distress syndrome (ARDS) has evolved, with recent trials
focusing on patients with more severe ARDS, and applying prone
ventilation for more prolonged periods.
Objectives:This review evaluates the effect of prone positioning on
28-day mortality (primary outcome) compared with conventional
mechanical ventilation in the supine position for adults with ARDS.
Methods:Weupdated the literature search froma systematic review
published in 2010, searching MEDLINE, EMBASE, and CENTRAL
(through toAugust 2016).We included randomized, controlled trials
(RCTs) comparing prone to supine positioning in mechanically
ventilated adults with ARDS, and conducted sensitivity analyses to
explore the effects of duration of prone ventilation, concurrent
lung-protective ventilation and ARDS severity. Secondary outcomes
includedPaO2/FIO2 ratio onDay 4 and an evaluation of adverse events.
Meta-analyses used random effects models. Methodologic quality
of the RCTs was evaluated using the Cochrane risk of bias
instrument, andmethodologic quality of the overall body of evidence
was evaluated using the GRADE (Grading of Recommendations
Assessment, Development, and Evaluation) guidelines.
Results: Eight RCTs fulﬁlled entry criteria, and included 2,129
patients (1,093 [51%] proned). Meta-analysis revealed no difference
inmortality (risk ratio [RR], 0.84; 95% conﬁdence interval [CI], 0.68–
1.04), but subgroup analyses found lower mortality with 12 hours or
greater duration prone (ﬁve trials; RR, 0.74; 95% CI, 0.56–0.99) and
for patients with moderate to severe ARDS (ﬁve trials; RR, 0.74; 95%
CI, 0.56–0.99). PaO2/FIO2 ratio on Day 4 for all patients was
signiﬁcantly higher in the prone positioning group (mean difference,
23.5; 95% CI, 12.4–34.5). Prone positioning was associated with
higher rates of endotracheal tube obstruction and pressure sores. Risk
of bias was low across the trials.
Conclusions:Prone positioning is likely to reducemortality among
patients with severe ARDS when applied for at least 12 hours daily.
Keywords: critical care; prone position; intensive care units; adult
respiratory distress syndrome; systematic review
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Mechanical ventilation in the prone
position, ﬁrst reported in 1970 (1), has been
evaluated as a strategy to enhance
oxygenation and lung recruitment in acute
respiratory failure. The mechanisms by
which prone positioning may beneﬁt
patients with acute respiratory distress
syndrome (ARDS) undergoing mechanical
ventilation include improving ventilation–
perfusion matching (2), increasing end-
expiratory lung volume (3), and preventing
ventilator-induced lung injury by more
uniform distribution of tidal volume
through lung recruitment and alterations in
chest wall mechanics. Early trials
persistently demonstrated improved
oxygenation (4–6). Although these trials
did not demonstrate a mortality beneﬁt
from prone positioning, post hoc analysis of
subgroups with more severe forms for
respiratory failure suggested beneﬁt (7).
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With a better understanding of the
appropriate target population, more recent
randomized trials attempted to address this
question with modern prone positioning
protocols, demonstrating promising results.
To inform the section on prone
positioning for the American Thoracic
Society/European Society of Intensive Care
Medicine/Society of Critical Care Medicine
Clinical Practice Guideline: Mechanical
Ventilation in Adult Patients with Acute
Respiratory Distress Syndrome, this analysis
aimed to determine the effect on mortality
(primary outcome) in adults with ARDS in
the prone position versus ventilation
exclusively in the supine position.
Methods
Search Strategy
We identiﬁed the most recent systematic
reviews of prone positioning in patients
with ARDS and performed an updated
systematic review to identify subsequent
relevant trials (see Appendix E1 in the
online supplement) (7, 8). A professional
librarian (E.U.) ran a search on the OvidSP
search platform in the MEDLINE and
EMBASE databases and the Wiley search
platform in the Cochrane Central Register
of Controlled Trials. We used both subject
headings and text-word terms to search for
articles on ARDS, prone positioning, and
adults (Cochrane, McMaster, Robinson
Dickersin clinical trials ﬁlters) (Appendix E2).
The results were limited to the publication
years 2009 to articles indexed as of August 8,
2016. We retrieved a total of 2,121 references.
All references were saved in an EndNote
(Philadelphia, PA) library used to identify the
373 duplicates. The remaining 1,748 unique
references were reviewed against our inclusion
criteria. There were no language restrictions.
Study Inclusion Criteria
Two reviewers (L.M. and L.D.S.)
independently reviewed all citations for
inclusion and extracted potentially relevant
studies for full-text review. Both reviewers
also independently reviewed the full text of
potentially relevant studies and decided on
eligibility. Any disagreements were resolved
by consensus with a third reviewer (E.F.). We
included randomized, controlled trials (RCTs)
that compared mechanical ventilation in the
prone position to ventilation in the supine
position in adults with ARDS and reported
mortality (7). Given the recent update in
ARDS criteria, any trials that enrolled patients
who, in hindsight, met the more recently
deﬁned Berlin criteria for ARDS were
included (9).
Data Extraction and Study Quality
A customized Excel (Microsoft Corporation,
Redmond, WA) spreadsheet was used to
store independently abstracted data on
study design, patient characteristics,
interventions, and study outcomes. All
studies were assessed for evidence of bias
using the Cochrane Collaboration risk of
bias instrument, including assessment for
random sequence generation, allocation
concealment, blinding of caregivers, and
outcome assessment, incomplete outcome
data and selective reporting and the use
of important cointerventions (10). We
considered a study’s overall risk of bias to
be high if any domain was judged to be at
high risk of bias, with the exception of
caregiver blinding, for which we accepted
standardization of mechanical ventilation
(while supine), sedation, and weaning in both
study arms to mitigate performance bias in
these necessarily unblinded trials. The GRADE
(Grading of Recommendations Assessment,
Development, and Evaluation) guidelines were
used for rating the quality of evidence (11).
Summary of Findings tables were prepared
using GRADEpro software (McMaster
University, Hamilton, ON, Canada, 2014) (12).
Outcomes
We analyzed the following outcomes in our
analysis, based on consensus among the
content experts in our group regarding
critical and important outcomes. Our
primary outcome was mortality within
28 days, or, if not available, then mortality
within 30 days in hospital or intensive care
(in that sequence). Secondary outcomes
included 90-day mortality, 6-month
mortality, absolute PaO2/FIO2 ratio on Day 4,
and adverse events (unplanned central
catheter removal, unplanned extubation,
endotracheal tube obstruction, ventilator-
associated pneumonia, and pressure sores).
Statistical Analysis
We reported dichotomous outcomes using
risk ratio (RR) and continuous outcomes
using mean difference, with 95% conﬁdence
intervals (CIs). For each analysis, studies
were weighted using the inverse variance
method, and data were pooled using a random
effects model (13). We assessed clinical
heterogeneity among studies qualitatively, and
statistical heterogeneity using the I2 measure (14).
A P value of 0.05 or less was considered to
be statistically signiﬁcant.
A series of a priori–determined
subgroup analyses were performed for
studies using lung-protective ventilation
(deﬁned as tidal volume< 8 ml/kg predicted
body weight) (15) compared with those
without lung-protective ventilation, duration
of prone position (>12 h compared with
,12 h), and severity of ARDS (trials
enrolling patients with moderate to severe
ARDS versus those enrolling patients with
any level of severity). These subgroups were
selected given their likelihood to reﬂect the
population and application of prone
positioning in current practice; furthermore,
this approach/population may reﬂect the
subgroup in which it may be the most
beneﬁcial. Mild ARDS was considered a
PaO2/FIO2 of 201–300 mm Hg, moderate was
considered a PaO2/FIO2 of 101–200 mm Hg,
and severe was considered a PaO2/FIO2 of less
than 100 mm Hg (9). All categorization for
severity of ARDS was based upon PaO2/FIO2
at randomization. For the latter analysis,
we also used within-trial subgroup data of
PaO2/FIO2 ratio, as previously published (7).
In a post hoc analysis to evaluate the
potential collinearity that may exist between
the use of lung-protective ventilation and
duration of time prone, a subgroup analysis
of duration of time prone (long vs. short)
was isolated to studies that just employed
lung-protective ventilation. This analysis was
repeated in studies that did not employ
lung-protective ventilation.
To assess publication bias, we visually
examined funnel plots of treatment effect
versus study precision. All statistical
analyses were performed using RevMan 5.2
(Cochrane Collaboration, Oxford, UK).
Results
The most recent systematic reviews
identiﬁed before this study were by Sud and
colleagues (7) and Abroug and colleagues (8).
The updated electronic search revealed
1,748 citations, of which 1 additional trial
met inclusion criteria (Appendix E3). We
excluded three trials included in the review
by Sud and colleagues, given that they did
not fulﬁll our inclusion criteria (16–18).
One study had a minimal focus on ARDS
(16), one study was a pediatric study (17),
and one study did not provide mortality
data (18).
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Eight RCTs met our inclusion criteria,
with a total of 2,129 patients (1,093 prone)
with ARDS and an overall median
(interquartile range) mortality rate of 45.0%
(27.5–49.5%) among those ventilated in the
prone position. Study characteristics are
summarized in Table 1. More recent studies
enrolled patients with more severe ARDS
(19–22), mandated a longer duration of
time prone (19–22), mandated lung-
protective ventilation in both arms
(6, 20–23), and mandated a lower
threshold for stopping prone positioning
(i.e., higher severity of illness in course
of ARDS, at which point prone positioning
was terminated—see Table 1) (21, 22). A
signiﬁcant proportion (63%) of initial
studies was terminated early due to slow
Table 2. Risk of bias (mortality outcome)
Study
(Reference)
Random
Sequence
Generation
(Selection Bias)
Allocation
Concealment
(Selection Bias)
Blinding of
Participants
and Personnel
(Performance Bias)
Blinding of
Outcome
Assessment
(Detection Bias)
Incomplete
Outcome Data
(Attrition Bias)
Selective
Reporting
(Reporting
Bias)
Gattinoni et al. 2001 (4) 1 1 2 1 1 1
Guerin et al. 2004 (5) 1 1 2 1 1 1
Voggenreiter et al. 2005 (6) 1 1 2 1 1 1
Mancebo et al. 2006 (19) 1 1 2 ? 1 1
Chan et al. 2007 (23) 1 2 2 ? 1 1
Fernandez et al. 2008 (22) 1 1 2 1 1 1
Taccone et al. 2009 (20) 1 1 2 1 1 1
Gue´rin et al. 2013 (21) 1 1 2 1 1 1
1 = risk of bias is low; 2 = risk of bias is high; ? = unknown risk of bias.
Table 3. Summary of ﬁndings: ventilation in the prone position compared to supine position for ARDS
Outcomes Illustrative Comparative Risks* (95% CI) RR (95% CI) No. of
Participants
(Studies)
Quality of the
Evidence
(GRADE)
Assumed Risk Corresponding Risk
Supine for ARDS Prone
Mortality 0.84 (0.68–1.04) 2,129 (8 studies) ÅÅÅ⊝ Moderate†
Study population 374 per 1,000 310 per 1,000 (250–388)
Moderate 348 per 1,000 289 per 1,000 (233–362)
Mortality, lung-protective
ventilation studies
0.70 (0.47–1.04) 906 (5 studies) ÅÅÅ⊝ Moderate‡
Study population 331 per 1,000 232 per 1,000 (156–344)
Moderate 331 per 1,000 232 per 1,000 (156–344)
Mortality, prolonged
duration prone >12 h
0.74 (0.56–0.99) 1,002 (5 studies) ÅÅÅÅ High
Study population 373 per 1,000 276 per 1,000 (209–369)
Moderate 364 per 1,000 269 per 1,000 (204–360)
Mortality, moderate to
severe ARDS studies
0.74 (0.56–0.99) 1,006 (5 studies) ÅÅÅ⊝ Moderate†
Study population 371 per 1,000 275 per 1,000 (208–367)
Moderate 364 per 1,000 269 per 1,000 (204–360)
Pressure sores 1.22 (1.06–1.41) 1,109 (3 studies) ÅÅÅÅ High
Study population 345 per 1,000 420 per 1,000 (365–486)
Moderate 188 per 1,000 229 per 1,000 (199–265)
Endotracheal tube
obstruction
1.76 (1.24–2.5) 1,594 (3 studies) ÅÅÅ⊝ Moderate†
Study population 98 per 1,000 172 per 1,000 (121–244)
Moderate 32 per 1,000 56 per 1,000 (40–80)
Definition of abbreviations: ARDS = acute respiratory distress syndrome; CI = confidence interval; GRADE =Grading of Recommendations Assessment,
Development, and Evaluation; RR = risk ratio.
Patient or population: patients with acute respiratory distress syndrome; intervention: ventilation in prone position; comparison: ventilation in supine position. GRADE
Working Group grades of evidence: high quality—further research is very unlikely to change our confidence in the estimate of effect; moderate quality—further
research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate; low quality—further research is very likely to
have an important impact on our confidence in the estimate of effect and is likely to change the estimate; very low quality—we are very uncertain about the estimate.
Å symbols indicate the number of GRADE criteria (out of 4) that were satisfied; ⊖ symbols indicate the number of GRADE criteria that were not satisfied.
*The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
†Optimal informal size insufficient.
‡Wide CIs.
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enrolment (4, 6, 19, 22, 23). Risk of bias for
our primary outcome was low across all
studies with the exception of one (23),
and is summarized in Table 2. Visual
inspection of a funnel plot did not
suggest publication bias (Appendix E6).
All results presented subsequently here are
summarized in Table 3.
Mortality
Four studies reported 28-day mortality
(5, 20, 21, 23), whereas one study provided
data on 30-day mortality (4), one on
in-hospital mortality (19), one on 60-day
mortality (22), and one on 90-day mortality
(6). Meta-analysis did not detect a
signiﬁcant difference in mortality between
prone and supine positioning (RR, 0.84;
Study or Subgroup
Favors Prone
Favours prone
Favors Supine
Favours supine
Events Total Events Total Weight
Risk Ratio
IV, Random, 95% CI
Risk Ratio
IV, Random, 95% CI
Heterogeneity: Tau2 = 0.04; Chi2 = 16.94, df = 7 (P = 0.02); I 2 = 59%
Test for overall effect: Z = 1.60 (P = 0.11)
345 372Total events
0.1 0.2 0.5 1 2 5 10
Total (95% CI) 0.84 [0.68, 1.04]10421099 100.0%
70Gattinoni et al. 2001 1.04 [0.82, 1.34]152 67 152 19.1%
134Guerin et al. 2004 1.03 [0.84, 1.26]413 119 378 20.9%
1Voggenreiter et al. 2005 0.30 [0.03, 2.66]21 3 19 0.9%
38Mancebo et al. 2006 0.81 [0.60, 1.10]76 37 60 17.0%
4Chan et al. 2007 1.00 [0.33, 3.02]11 4 11 3.2%
8Fernandez et al. 2008 0.72 [0.36, 1.45]21 10 19 6.9%
52Taccone et al. 2009 0.94 [0.69, 1.29]168 57 174 16.6%
38Guerin et al. 2013 0.49 [0.35, 0.69]237 75 229 15.3%
Figure 1. Primary outcome: mortality. Forest plot demonstrating pooled data of early mortality across all randomized trials using a random effects
model. Early mortality was defined as 28-day mortality used for all studies where available; for Gattinoni and colleagues (4), 30-day mortality was
used, for Voggenreiter and colleagues (6), 90-day mortality was used, for Fernandez and colleagues (22), 60-day mortality was used, and for
Mancebo and colleagues (19), in-hospital mortality was used. The arrowhead indicates that the lower confidence interval is beyond the x-axis of the graph.
CI = confidence interval; df = degrees of freedom; Events = number of deaths; I2 = statistical heterogeneity; IV = inverse variance; Total = total number of patients.
Study or Subgroup
 Lung Protective Ventilation Studies
 Non-Lung Protective Ventilation Studies
Prone
Favors prone
Supine
Favors supine
Events Total Events Total Weight
Risk Ratio
IV, Random, 95% CI
Risk Ratio
IV, Random, 95% CI
Heterogeneity: Tau2 = 0.09; Chi2 = 8.70, df = 4 (P = 0.07); I 2 = 54%
Test for overall effect: Z = 1.76 (P = 0.08)
Heterogeneity: Tau2 = 0.00; Chi2 = 2.02, df = 2 (P = 0.37); I 2 = 1%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Chi2 = 2.50, df = 1 (P = 0.11), I 2 = 60.0%
0.2 0.5 2 50.1 1 10
223242Total events
Total events 103 149
456Subtotal (95% CI) 0.70 [0.47, 1.04]100.0%450
Subtotal (95% CI) 0.98 [0.85, 1.13]100.0%641 590
3211 0.30 [0.03, 2.66]Voggenreiter et al. 2005 19 3.1%
11 114 4 1.00 [0.33, 3.02]Chan et al. 2007 9.9%
10218 0.72 [0.36, 1.45]Fernandez et al. 2008 19 18.8%
1725716652 0.95 [0.69, 1.29]Taccone et al. 2009 35.0%
7523738 0.49 [0.35, 0.69]Guerin et al. 2013 229 33.3%
1526715270Gattinoni et al. 2001 1.04 [0.82, 1.34]31.6%
378119413134 1.03 [0.84, 1.26]Guerin et al. 2004 46.8%
60377638 0.81 [0.60, 1.10]Mancebo et al. 2006 21.6%
Figure 2. Primary outcome:mortality; sensitivity analysis: studies, including lung-protective ventilation. Forest plot demonstrating pooled data of early mortality in studies
employing lung-protective ventilation versus those without lung-protective ventilation using a random effects model. Early mortality was defined as 28-day mortality
used for all studies where available; for Gattinoni and colleagues (4), 30-day mortality was used, for Voggenreiter and colleagues (6), 90-day mortality was used, for
Fernandez and colleagues (22), 60-daymortality was used, and for Mancebo and colleagues (19), in-hospital mortality was used. The arrowhead indicates that the lower
confidence interval is beyond the x-axis of the graph. CI = confidence interval; df =degrees of freedom; Events=number of deaths; I2 = statistical heterogeneity;
IV= inverse variance; Total = total number of patients.
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95% CI, 0.68–1.04; I2, 59%; Figure 1).
Similarly, a subgroup analysis limited to
studies that applied lung-protective
ventilation (6, 20–23) detected no
signiﬁcant reduction in mortality with
lung protection (ﬁve trials; RR, 0.70; 95%
CI, 0.47–1.04; I2, 54%), and the test for
subgroup effect was not statistically
signiﬁcant (P = 0.11) (Figure 2).
The impact of the duration of prone
positioning was evaluated comparing studies
of longer versus shorter durations of prone
positioning. Mortality was reduced in the ﬁve
trials (18–23) in which patients were proned
for 12 hours or longer daily (RR, 0.74; 95%
CI, 0.56–0.99; I2, 53%) compared with three
trials that proned patients for less than 12
hours daily (RR, 1.03; 95% CI, 0.88–1.20; I2,
0%; P for subgroup difference, 0.05; Figure 3).
Finally, mortality was stratiﬁed by
study-level severity of ARDS inclusion
criteria according to the Berlin deﬁnition (all
ARDS vs. only moderate to severe ARDS),
and a mortality difference favoring
moderate to severe ARDS studies was noted
(RR, 0.74; 95% CI, 0.54–0.99; I2, 53%; all
ARDS: RR, 1.03; 95% CI, 0.88–1.20; I2, 0%;
P for subgroup differences, 0.05; Figure 4).
The impact of prone positioning on
mortality based upon severity of ARDS was
also analyzed using published subgroup data
(7) obtained from each study (severe: RR,
0.82; 95% CI, 0.72–0.93; I2, 0%; mild to
moderate: RR, 0.90; 95% CI, 0.68–1.17;
I2, 65%; Appendix E4; P for subgroup
difference, 0.57). Of note, in the latter
analysis, the mortality time points were
obtained from the last known follow-up
time, and there were no “mild” (PaO2/FIO2
200–300) cases of ARDS in ﬁve of the
studies (19–23).
Given that the predominant studies
driving the non–lung-protective ventilation
subgroup were also the studies that
employed a shorter-duration prone position
(4, 5), an exploratory post hoc analysis was
performed in attempt to delineate the impact
of duration of time prone independent
of the effect of lung-protective ventilation
(Appendix E5). These analyses, limited
by the small numbers of studies in the
comparator subgroups, did not demonstrate
any difference in mortality between prone
positioning and supine positioning.
There was moderate clinical and
statistical heterogeneity noted for the pooled
mortality outcome assessment across
studies. The overall quality of evidence for
our primary and secondary outcomes was
graded as moderate to high (Table 3).
Secondary Outcomes
Meta-analyses for secondary outcomes,
including 90-day mortality and 6-month
mortality, did not demonstrate a difference
between prone and supine positioning
(Appendix E4). PaO2/FIO2 ratio on Day 4 was
signiﬁcantly higher in the prone-positioning
group compared with the supine position
group (mean difference, 23.5; 95% CI, 12.4–
34.5; I2, 24%; Appendix E4).
Adverse Events
Four studies reported on barotrauma and
ventilator-associated pneumonia (5, 19, 22,
23), three studies on unplanned central
catheter removal during prone positioning
(4, 20, 23), and eight studies on unplanned
extubation (4–6, 19–23). Meta-analyses
showed no differences between prone
positioning compared with supine
Study or Subgroup
 12h Prone
 12h Prone
Prone
Favors prone
Supine
Favors supine
Events Total Events Total Weight
Risk Ratio
IV, Random, 95% CI
Risk Ratio
IV, Random, 95% CI
Heterogeneity: Tau2 = 0.00; Chi2 = 1.24, df = 2 (P = 0.54); I 2 = 0%
Test for overall effect: Z = 0.36 (P = 0.72)
Heterogeneity: Tau2 = 0.05; Chi2 = 8.53, df = 4 (P = 0.07); I 2 = 53%
Test for overall effect: Z = 2.06 (P = 0.04)
Test for subgroup differences: Chi2 = 3.92, df = 1 (P = 0.05), I 2 = 74.5%
0.2 0.5 2 50.1 1 10
Total events 205 189
Total events 183140
Subtotal (95% CI) 1.03 [0.88, 1.20]100.0%586 549
60377638 0.81 [0.60, 1.10]Mancebo et al. 2006 28.5%
11 114 4 1.00 [0.33, 3.02]Chan et al. 2007 5.7%
10218 0.72 [0.36, 1.45]Fernandez et al. 2008 19 12.0%
1725716652 0.95 [0.69, 1.29]Taccone et al. 2009 27.9%
7523738 0.49 [0.35, 0.69]Guerin et al. 2013 229 25.8%
1526715270Gattinoni et al. 2001 1.04 [0.82, 1.34]40.0%
378119413134 1.03 [0.84, 1.26]Guerin et al. 2004 59.5%
3211 0.30 [0.03, 2.66]Voggenreiter et al. 2005 19 0.5%
Subtotal (95% CI) 0.74 [0.56, 0.99]100.0%491511
Figure 3. Primary outcome: mortality; subgroup analysis: duration of time prone. Forest plot demonstrating pooled data of early mortality in studies with
a longer duration of time prone (>12 h) versus a shorter time (,12 h) using a random effects model. Early mortality was defined as 28-day mortality
used for all studies where available; for Gattinoni and colleagues (4), 30-day mortality was used, for Voggenreiter and colleagues (6), 90-day mortality
was used, for Fernandez and colleagues (22), 60-day mortality was used, and for Mancebo and colleagues (19), in-hospital mortality was used.
The arrowhead indicates that the lower confidence interval is beyond the x-axis of the graph. CI = confidence interval; df = degrees of freedom;
Events = number of deaths; I2 = statistical heterogeneity; IV = inverse variance; Total = total number of patients.
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positioning (Appendix E4). However, there
were increased risks of endotracheal tube
obstruction (RR, 1.76; 95% CI, 1.24–2.50;
I2, 26%; three studies [5, 20, 21]) and
pressure sores (RR, 1.22; 95% CI, 1.06–1.41;
I2, 0%; three studies [4, 5, 23]) with prone
positioning (Appendix E4).
Discussion
Our systematic review and meta-analysis
pooled results from eight randomized trials
conducted over 12 years. Although the
primary meta-analysis did not demonstrate
a mortality difference, a priori subgroup
analyses demonstrated lower mortality
when prone positioning was applied for
12 hours or longer per day and in studies
including moderate to severe ARDS. Given,
however, that the within-trial subgroup
analysis of severe ARDS versus mild to
moderate ARDS did not demonstrate a
statistically signiﬁcant difference between
the two subgroups, despite there being a
mortality beneﬁt with severe ARDS
(Appendix E4), the speciﬁc PaO2/FIO2
threshold at which one might beneﬁt
from prone positioning is not entirely clear.
The trials also facilitated meta-analyses
of important complications of prone
positioning, which revealed an increase
in endotracheal tube obstruction and
pressure sores.
The evolution of the evidence for prone
positioning demonstrates how the beneﬁt of
an important and effective adjuvant therapy
may not be obvious until applied in the
optimal manner and to the right population.
Our ﬁndings highlight the importance of
identifying a responsive target population
and mastering the speciﬁcs of the
intervention’s execution.
Prone positioning appears to beneﬁt
more hypoxemic patients with ARDS,
and particularly when applied for a longer
daily duration. Those with the most
severe lung injury have the greatest
physiologic rationale for beneﬁts from
prone positioning, due to more severe and
heterogeneous lung injury and greater
ventilation–perfusion heterogeneity in the
dependent lung zones while supine. Placing
a patient in the prone position facilitates
recruitment and decreases heterogeneity of
compliance, which improves oxygenation
and minimizes injurious ventilation (24).
Application of prone positioning yielded
the greatest beneﬁt in studies in which it
was applied for 12 hours or longer per day.
This is not surprising, as a decrease in
ventilator-induced lung injury is likely the
mechanism by which prone positioning
decreases mortality, and longer periods of
prone ventilation means less injury (21). As
such, prone positioning could be perceived
as a treatment to be initiated early, at the
appropriate severity of ARDS, and at the
correct dose (>12 h). Three systematic
reviews and study-level meta-analyses
(24–26) have been published since the most
recent RCT. Lee and colleagues (25)
included 11 RCTs, 3 of which we excluded.
They found that prone positioning
signiﬁcantly reduced mortality (odds ratio,
0.77; 95% CI, 0.59–0.99; P, 0.039; I2, 33.7%).
The difference in results may arise from the
time point of the mortality assessment (their
Study or Subgroup
 Moderate to Severe ARDS
 All ARDS
Prone
Favours prone
Supine
Favours supine
Events Total Events Total Weight
Risk Ratio
IV, Random, 95% CI
Risk Ratio
IV, Random, 95% CI
Heterogeneity: Tau2 = 0.04; Chi2 = 16.94, df = 7 (P = 0.02); I 2 = 59%
Test for overall effect: Z = 1.60 (P = 0.11)
Heterogeneity: Tau2 = 0.00; Chi2 = 1.24, df = 2 (P = 0.54); I 2 = 0%
Test for overall effect: Z = 0.36 (P = 0.72)
Heterogeneity: Tau2 = 0.05; Chi2 = 8.51, df = 4 (P = 0.07); I 2 = 53%
Test for overall effect: Z = 2.06 (P = 0.04)
Test for subgroup differences: Chi2 = 3.93, df = 1 (P = 0.05), I 2 = 74.6%
0.2 0.50.1 2 51 10
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Total events 345 372
Total events 183140
60377638 0.81 [0.60, 1.10]Mancebo et al. 2006 17.0%
11 114 4 1.00 [0.33, 3.02]Chan et al. 2007 3.2%
10218 0.72 [0.36, 1.45]Fernandez et al. 2008 19 6.9%
1745716852 0.94 [0.69, 1.29]Taccone et al. 2009 16.6%
7523738 0.49 [0.35, 0.69]Guerin et al. 2013 229 15.3%
1526715270Gattinoni et al. 2001 1.04 [0.82, 1.34]19.1%
378119413134 1.03 [0.84, 1.26]Guerin et al. 2004 20.9%
205 189
3211 0.30 [0.03, 2.66]Voggenreiter et al. 2005 19 0.9%
Subtotal (95% CI) 1.03 [0.88, 1.20]40.9%549586
Subtotal (95% CI) 0.74 [0.56, 0.99]59.1%493513
Total (95% CI) 0.84 [0.68, 1.04]100.0%1099 1042
Figure 4. Primary outcome: mortality; subgroup analysis according to study entry criteria of moderate to severe acute respiratory distress syndrome (ARDS) versus
all ARDS. Forest plot demonstrating pooled data of early mortality in studies of moderate to severe ARDS versus studies enrolling all types of ARDS using a random
effects model. Early mortality was defined as 28-day mortality used for all studies where available; for Gattinoni and colleagues (4), 30-day mortality was used,
for Voggenreiter and colleagues (6), 90-day mortality was used, for Fernandez and colleagues (22), 60-day mortality was used, and for Mancebo and colleagues
(19), in-hospital mortality was used. The arrowhead indicates that the lower confidence interval is beyond the x-axis of the graph. CI = confidence interval; df = degrees
of freedom; Events = number of deaths; I2 = statistical heterogeneity; IV = inverse variance; Total = total number of patients.
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trial included mortality at the longest-
available follow-up) or differences in trial
selection (one trial did not focus primarily on
ARDS [15] and two trials combined prone
positioning with high-frequency oscillation
[27, 28]). Sud and colleagues (7) included 11
trials and found a signiﬁcantly reduced
mortality favoring prone positioning in the
cohort of studies with reduced tidal volume
(RR, 0.74, 95% CI, 0.59–0.95; I2, 29%). The
difference found in their results can be
attributed to three additional studies
(Appendix E3) (16, 18, 27), and the fact that
the mortality time point chosen was obtained
at the longest period of follow-up. Contrary
to our review, which chose the earlier
mortality time point (28 d), obtaining data
from the longest period of follow-up is a
reasonable alternative approach for pooling
mortality data.
Our review is unique in that we
established, a priori, a series of important
subgroup analyses to reﬂect contemporary
application of prone positioning. The large
number of studies allowed us to conduct
meta-analyses of adverse events. It is
important to highlight several limitations to
our review. Given the evolution of the
target population (progressively more
severe ARDS) and the longer duration of
prone positioning, our primary analysis
captured three studies that included
outdated approaches to prone positioning,
given their short duration in the prone
position (4–6). We did not restrict our
inclusion criteria to more contemporary
trials; therefore, we were limited in our
ability to address which features conferred
the greatest beneﬁt (i.e., lung-protective
ventilation, duration of time prone, and
restriction of entry to patients with
moderate to severe ARDS); however, we
attempted to capture this during our
subgroup analyses. Including the entire
body of evidence facilitated an extensive
exploration of important adverse events.
Although we found that daily duration of
proning of at least 12 hours reduced
mortality, the exact threshold required to
confer beneﬁt remains unknown. Finally,
the hypoxemia threshold at which prone
positioning is beneﬁcial has not been
deﬁnitively established. Although the meta-
analysis of trials of moderate to severe
ARDS (i.e., PaO2/FIO2, 200) demonstrated
reduced mortality, the more recent trial by
Gue´rin and colleagues (21) included
patients with a PaO2/FIO2 ratio of 150 or less.
Within-trial subgroup data based on this
threshold were not available from all
studies to establish the validity of this
threshold among all trials. Finally, despite
the numerous subgroup analyses, it was
not possible to deﬁnitively address the
potential collinearity that arises between
duration of time prone and lung-protective
ventilation, as well as duration of time
prone and severity of illness. Although,
for the former, we performed post hoc
analyses (Appendix E5), this was limited in
that the comparator groups were single
studies, and we therefore interpret these
results with caution. With regard to
collinearity that may exist between duration
of time prone and severity of illness, we
attempted to explore this through the
study-level subgroup analysis; however,
an individual patient-level meta-analysis
would be the optimal approach to exploring
this potential collinearity.
Conclusions
In our systematic review of eight randomized
trials evaluating prone positioning
compared with supine positioning for adults
undergoing mechanical ventilation, we
found a reduction in mortality when the
prone position is used in patients with
moderate to severe ARDS (PaO2/FIO2, 200)
and for a longer duration (>12 h). Prone
positioning is not without harm, however,
and is associated with an increased risk
of endotracheal tube obstruction and
pressure sores. n
Author disclosures are available with the text
of this article at www.atsjournals.org.
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